Clinical trials
Hypercholesterolemia trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 11 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 63 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 15 |
| Sanofi | 12 |
| Kowa Research Europe | 6 |
| AstraZeneca | 5 |
| Maastricht University Medical Center | 5 |
| Novartis Pharmaceuticals | 5 |
| Kastle Therapeutics, LLC | 4 |
| Merck Sharp & Dohme LLC | 3 |
| NewAmsterdam Pharma | 3 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 81 |
| Dyslipidemias | 21 |
| Hyperlipidemias | 16 |
| Cardiovascular Diseases | 9 |
| Hyperlipoproteinemia Type II | 9 |
| Atherosclerosis | 8 |
| Homozygous Familial Hypercholesterolemia | 8 |
| Lipid Metabolism Disorders | 5 |
| Hypertension | 4 |
| Metabolic Diseases | 4 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.